glutamine has been researched along with mitoxantrone in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Feneberg, W; Hoffmann, LA; Hohlfeld, R; Kümpfel, T; Lohse, P; Pellkofer, H; Pöllmann, W | 1 |
1 review(s) available for glutamine and mitoxantrone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for glutamine and mitoxantrone
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 cases.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arginine; Familial Mediterranean Fever; Female; Genetic Predisposition to Disease; Glatiramer Acetate; Glutamine; HLA-D Antigens; Humans; Immunosuppressive Agents; Male; Middle Aged; Mitoxantrone; Multiple Sclerosis; Mutation; Natalizumab; Penetrance; Peptides; Phenotype; Receptors, Tumor Necrosis Factor, Type I; Sequence Analysis, DNA; Young Adult | 2008 |